Top news
EXPLAINER: New drug slows Alzheimer's but comes with caveats
By Lauran Neergaard & Matthew Perrone
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
By Spencer Kimball
FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
By Pam Belluck
FDA grants Alzheimer's drug Leqembi accelerated approval : Shots - Health News
By Jon Hamilton
All coverage
Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns
By Jacqueline Howard & Brenda Goodman
New Alzheimer's Drug Approved by FDA, Promises to Slow Disease
By Joseph Walker
Eisai, Biogen get U.S. FDA approval for Alzheimer's drug, apply for full approval
By Julie Steenhuysen & Deena Beasley
FDA Approves Lecanemab, a New Alzheimer's Drug
By Alice Park
Alzheimer's drug that slows cognitive decline gets FDA approval
By Laurie McGinley
A new Alzheimer’s drug will cost $26,500 a year. Who will be able to get it?
By Berkeley Lovelace & Berkeley Lovelace Jr.
FDA approves new Alzheimer's drug Leqembi
By Adam Feuerstein
FDA approves new antibody to slow Alzheimer's disease, even as safety concerns linger
By Jennifer Couzin
FDA approves new Alzheimer’s drug that appears to slow disease
By Berkeley Lovelace & Berkeley Lovelace Jr.